Stem cell models as an in vitro model for predictive toxicology.

Area of Science:

• Toxicology
• Drug Development
• Stem Cell Biology

Background:

• Adverse drug reactions (ADRs) are unpredictable and pose significant risks.
• Traditional animal models for toxicity testing have limitations in predicting human responses.
• High-profile failures highlight the need for improved predictive models in drug development.

Purpose of the Study:

• To review the current state of stem cell-derived models for predicting drug toxicity.
• To address the potential of stem cell technologies in improving ADR predictability.
• To discuss the emerging need for modeling gastrointestinal toxicity.

Main Methods:

• Review of current literature on stem cell-derived models for toxicity.
• Analysis of differentiated 2D stem cell cultures for hepato- and cardiotoxicity.
• Discussion of stem cell technologies for modeling ADRs.

Main Results:

• Stem cell models retain individual genotypes, enabling in vitro modeling of rare phenotypes.
• Current stem cell models, particularly for hepatotoxicity, may lack sufficient maturity for widespread use.
• There is an ongoing need to develop more accurate models for predicting complex ADRs.

Conclusions:

• Stem cell technologies show potential for enhancing the accuracy of ADR prediction.
• Further development is needed to overcome limitations in stem cell model maturity and application.
• Stem cell-derived models may offer a solution for predicting off-target and unpredictable drug toxicities.